![](/img/cover-not-exists.png)
[105] EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE DOSE OF SIMVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE (CHD), WITH AND WITHOUT DIABETES (T2DM), NOT AT LDL-C TARGET WITH SIMVASTATIN ALONE: A POOLED ANALYSIS OF TWO DOUBLE-BLIND, RANDOMIZED ITALIAN STUDIES
C.M. Rotella, A. Zaninelli, C. Le Grazie, G.F. GensiniVolume:
19
Year:
2009
Language:
english
DOI:
10.1016/s0939-4753(09)70106-1
File:
PDF, 68 KB
english, 2009